surmount-1 trial tirzepatide non-diabetic weight loss for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled SURMOUNT-1: Adults achieve weight loss

Buckley ST, Baekdal TA, Vegge A, et al

Both medications contain glucagon-like peptide-1 (GLP-1) receptor agonists

6 , e13852 (2018)

If you experienced menstrual changes on tirzepatide , tracking these through discontinuation helps you understand when your cycle returns to baseline

It increases insulin production, a hormone that lowers the blood sugar level while inhibiting glucagon secretion, which is a hormone that raises blood sugar, and reduces appetite and energy intake while delaying gastric emptying

In 2023, the company generated solid YOY growth, with sales up 9% and expects to remain in a good position thanks to its robust pipeline